Literature DB >> 26487289

Mesorectal pathologic assessment in two grades predicts accurately recurrence, positive circumferential margin, and correlates with survival.

Leonardo S Lino-Silva1, Miguel A García-Gómez2, José M Aguilar-Romero3, Jorge A Domínguez-Rodríguez3, Rosa A Salcedo-Hernández2, Reynaldo Loaeza-Belmont1, Erika B Ruiz-García4, Ángel Herrera-Gómez2.   

Abstract

BACKGROUND AND OBJECTIVES: We aimed to determine the prognostic value of the mesorectum quality assessed in a two-grade system compared with a classic system.
METHODS: Consecutive patients undergoing surgery for rectal cancer were included (n = 103). Mesorectum was assessed into three grades (classic system: complete, nearly complete, incomplete) and compared with a two-grade system (adequate, inadequate).
RESULTS: Mesorectum was complete in 62 (60.25%) patients, nearly complete in 21, and incomplete in 20. Reassessment showed adequate mesorectum in 83 (80.5%) patients and inadequate in 20. A R0 resection was achieved in 90.4% of adequate mesorectum and in 65% of inadequate mesorectum (P = 0.006). Recurrence was present in 18% of adequate mesorectum patients as compared with 50% of inadequate mesorectum (P = 0.003). The classic system failed to accurately predict the 5-year survival rate between complete (78.9%) and nearly complete (86.2%) categories (P = 0.235); whereas a two grading system showed a 5-year survival rate of 80.8% for adequate versus 39.3% for inadequate (P = 0.034).
CONCLUSION: High recurrence occurred in inadecuate mesorectum patients and was correlated with R1/R2 resections, positive margins, and decreased survival. We propose a simplified classification of mesorectum that correlates with survival and overall recurrence.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; colorectal; mesorectum; total mesorectal excision

Mesh:

Year:  2015        PMID: 26487289     DOI: 10.1002/jso.24076

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy.

Authors:  Leonardo S Lino-Silva; Rosa A Salcedo-Hernández; Erika B Ruiz-García; Leticia García-Pérez; Ángel Herrera-Gómez
Journal:  Med Arch       Date:  2016-07-27

2.  GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.

Authors:  Kunli Zhu; Qianqian Zhao; Jinbo Yue; Pengyue Shi; Hongjiang Yan; Xiaoqing Xu; Renben Wang
Journal:  Oncotarget       Date:  2016-10-18

3.  Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study.

Authors:  Leonardo S Lino-Silva; Armando Gamboa-Domínguez; Diego Zúñiga-Tamayo; Rosa A Salcedo-Hernández; Lucely Cetina; David Cantú-de-León
Journal:  World J Clin Oncol       Date:  2018-11-10

4.  Comparison of the operative outcomes and learning curves between laparoscopic and "Micro Hand S" robot-assisted total mesorectal excision for rectal cancer: a retrospective study.

Authors:  Yanlei Wang; Guohui Wang; Zheng Li; Hao Ling; Bo Yi; Shaihong Zhu
Journal:  BMC Gastroenterol       Date:  2021-06-07       Impact factor: 3.067

5.  Overweight but not obesity is associated with decreased survival in rectal cancer.

Authors:  Leonardo S Lino-Silva; Eduardo Aguilar-Cruz; Rosa A Salcedo-Hernández; César Zepeda-Najar
Journal:  Contemp Oncol (Pozn)       Date:  2018-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.